MK cell therapy (Roquefort Therapeutics)

N/A

Report date: 2025/06/11 10:45:14

Base Information

Drug NameMK cell therapy (Roquefort Therapeutics)
Drug Alias NameMK cell therapy (Roquefort Therapeutics)
ClassificationBiologics
Mechanisms of ActionNatural killer cells stimulants
TargetsUpdating
Therapy Area/IndicationsMultiple MyelomaLymphomaLeukemia, Myelogenous, Chronic +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOncogeni Ltd
China Registration ClassN/A

Develop Information

Active CompaniesRoquefort Therapeutics plc
Inactive CompaniesOncogeni Ltd
Active IndicationsMultiple MyelomaLymphomaLeukemia, Myelogenous, Chronic +[4] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A